A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay

Summary: Evaluating the neutralizing antibody titer following SARS-CoV-2 vaccination is essential in defining correlates of protection. We describe an assay that uses single-cycle vesicular stomatitis virus (VSV) pseudoviruses linking a fluorophore with a spike (S) from a variant of concern (VOC). U...

Full description

Bibliographic Details
Main Authors: Benjamin Louis Sievers, Terri Gelbart, Gene S. Tan
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166722007158
_version_ 1797980858307575808
author Benjamin Louis Sievers
Terri Gelbart
Gene S. Tan
author_facet Benjamin Louis Sievers
Terri Gelbart
Gene S. Tan
author_sort Benjamin Louis Sievers
collection DOAJ
description Summary: Evaluating the neutralizing antibody titer following SARS-CoV-2 vaccination is essential in defining correlates of protection. We describe an assay that uses single-cycle vesicular stomatitis virus (VSV) pseudoviruses linking a fluorophore with a spike (S) from a variant of concern (VOC). Using two fluorophores linked to two VOC S, respectively, allows us to determine the neutralization titer against two VOCs in a single run. This is a generalizable approach that saves time, samples, and run-to-run variability.For complete details on the use and execution of this protocol, please refer to Sievers et al. (2022).1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
first_indexed 2024-04-11T06:00:23Z
format Article
id doaj.art-fdb4223a59ff40fda1396cf44b267e5b
institution Directory Open Access Journal
issn 2666-1667
language English
last_indexed 2024-04-11T06:00:23Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series STAR Protocols
spelling doaj.art-fdb4223a59ff40fda1396cf44b267e5b2022-12-22T04:41:43ZengElsevierSTAR Protocols2666-16672022-12-0134101835A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assayBenjamin Louis Sievers0Terri Gelbart1Gene S. Tan2J. Craig Venter Institute, La Jolla, CA 92037, USAJ. Craig Venter Institute, La Jolla, CA 92037, USAJ. Craig Venter Institute, La Jolla, CA 92037, USA; Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA; Corresponding authorSummary: Evaluating the neutralizing antibody titer following SARS-CoV-2 vaccination is essential in defining correlates of protection. We describe an assay that uses single-cycle vesicular stomatitis virus (VSV) pseudoviruses linking a fluorophore with a spike (S) from a variant of concern (VOC). Using two fluorophores linked to two VOC S, respectively, allows us to determine the neutralization titer against two VOCs in a single run. This is a generalizable approach that saves time, samples, and run-to-run variability.For complete details on the use and execution of this protocol, please refer to Sievers et al. (2022).1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.http://www.sciencedirect.com/science/article/pii/S2666166722007158Cell-based AssaysHigh Throughput ScreeningMicrobiologyAntibody
spellingShingle Benjamin Louis Sievers
Terri Gelbart
Gene S. Tan
A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
STAR Protocols
Cell-based Assays
High Throughput Screening
Microbiology
Antibody
title A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
title_full A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
title_fullStr A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
title_full_unstemmed A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
title_short A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
title_sort high throughput sars cov 2 pseudovirus multiplex neutralization assay
topic Cell-based Assays
High Throughput Screening
Microbiology
Antibody
url http://www.sciencedirect.com/science/article/pii/S2666166722007158
work_keys_str_mv AT benjaminlouissievers ahighthroughputsarscov2pseudovirusmultiplexneutralizationassay
AT terrigelbart ahighthroughputsarscov2pseudovirusmultiplexneutralizationassay
AT genestan ahighthroughputsarscov2pseudovirusmultiplexneutralizationassay
AT benjaminlouissievers highthroughputsarscov2pseudovirusmultiplexneutralizationassay
AT terrigelbart highthroughputsarscov2pseudovirusmultiplexneutralizationassay
AT genestan highthroughputsarscov2pseudovirusmultiplexneutralizationassay